SBI Mutual Fund trimmed its stake in Abbott India from 2.16% to 1.92%, selling 50,497 shares.
A leading multinational pharmaceutical company operating in India since 1944, Abbott India manufactures and distributes a comprehensive portfolio of medicines, nutritional products, and diagnostic solutions across the country. The company serves the Indian market through an extensive network of independent distributors, focusing on therapeutic areas including cardiovascular health, gastroenterology, and nutrition. Its integrated operations span research, development, and commercialization of pharmaceutical products tailored to meet diverse Indian healthcare needs and patient requirements.
India's largest AMC by total AUM, managing over Rs 11 lakh crore across equity, debt and hybrid schemes. Backed by State Bank of India, the country's largest bank, which gives it unmatched retail reach across every Indian state. With over 70 schemes and 50 million folios, SBI MF's positioning moves are tracked as a proxy for domestic institutional flows.
